RxDoctor Payments Data

Orry Erez, MD

Orthopaedic Surgery · Brooklyn, NYNPI 1609085786

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $730 of the $1,077 with a category attached, or 67.8%. Stryker accounts for 71.3% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $565, 5.3 times the $107 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$1,077in general payments, 2019–2025

Across 22 payments — averaging $48.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$768
  • Intellijoint Surgical Inc.$197
  • Johnson & Johnson$52
  • Sanofi-aventis U.S. LLC$39
  • Endo Pharmaceuticals Inc.$22

What the payments were for

  • Travel & lodging$34732%
  • Food & beverage$73068%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,077 in reported general payments places this provider in the 30th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$155,359
Medicare patients
330
Services billed
2,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MeloxicamMeloxicam, Submicronized21$9,882
Diclofenac Sodium140$6,547
Celecoxib85$839
Meloxicam312$790
Oxycodone Hcl33$119
Ibuprofen13$66

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →